OTC · Biotechnology

GeneLink, Inc. (GNLKQ) Stock

$0.00 OTC: GNLKQ Healthcare

GeneLink, Inc. specializes in delivering 12-gene DNA profiling services.

Valuation

MetricValue
Price$0.00
Market Cap$10601
P/E Ratio0.00
P/B Ratio0.00
P/S Ratio0.01
EPS (TTM)$0.00
52-Week High$0.00
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE100.00%
ROA-69.12%
ROCE902.77%
Gross Margin19.40%
Operating Margin-204.69%
Net Margin-141.05%
Debt/Equity0.00
Current Ratio0.34

Annual Financials (USD)

Metric20082009201020112012
Revenue$6.0M$9.0M$8.0M$5.0M$2.0M
Operating Profit$-2.0M$-2.0M$-2.0M$-4.0M$-3.0M
Net Profit$-3.0M$-3.0M$-3.0M$-4.0M$-3.0M
EPS$-0.03$-0.03$-0.02$-0.02$-0.01
Op Margin-35.0%-28.8%-30.6%-76.1%-162.4%

Balance Sheet (USD)

Metric20082009201020112012
Total Assets$3.0M$2.0M$2.0M$3.0M$1.0M
Total Liabilities$2.0M$3.0M$3.0M$4.0M$4.0M
Cash$0$0$0$1.0M$0
Borrowings$0$0$0$0$0

Cash Flow (USD)

Metric20082009201020112012
Operating Cash Flow$-1.0M$-3.0M$-1.0M$-3.0M$-2.0M
Investing Cash Flow$-1.0M$0$0$0$0
Financing Cash Flow$1.0M$1.0M$0$1.0M$0
Net Cash Flow$-1.0M$0$0$0$-1.0M
Free Cash Flow$-2.0M$-3.0M$-1.0M$-3.0M$-3.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA0.06
FCF Yield-24767.22%
Quick Ratio0.21
Interest Coverage-10.48
Return 1Y0.00%
Return 3Y-60.00%
Return 5Y—

Ownership

Insiders Held0.00%
Institutions Held0.00%
Institutions Float Held0.00%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BSSPBaseline Productions, Inc. $0.00 — -0.02 $74377 0.00%
CNBXCNBX Pharmaceuticals Inc. $0.00 — 0.10 $9251 0.00%
ENDVEndonovo Therapeutics, Inc. $0.00 — 1.00 $31875 0.00%
FLHLFFilament Health Corp. $0.00 — -1.89 $26179 0.00%
GMVDFG Medical Innovations Holdings Ltd $0.00 — 0.00 $25992 0.00%

About GeneLink, Inc.

GeneLink, Inc. specializes in delivering 12-gene DNA profiling services. Beyond genetic analyses, the company also provides clients with bespoke nutritional supplements tailored to individual health needs. Additionally, the firm crafts a comprehensive collection of dermatological products. Established in 1994, GeneLink, Inc. maintains its headquarters in Orlando, Florida.

GeneLink, Inc. (GNLKQ) stock trades at $0.00 with a market capitalization of $10601. The stock is valued at price-to-book of 0.00, price-to-sales of 0.01.

On profitability, GeneLink, Inc. generates a return on equity (ROE) of 100.00%, above the typical market range of roughly 12-15%, return on capital employed of 902.77%, an operating margin of -204.69%, a net profit margin of -141.05%.

Official website: www.genelink.com

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.